Dr Joel C Everett, MD | |
13821 Village Mill Dr, Midlothian, VA 23114-4365 | |
(804) 794-2821 | |
(804) 794-4072 |
Full Name | Dr Joel C Everett |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 13821 Village Mill Dr, Midlothian, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053327148 | NPI | - | NPPES |
128507 | Other | VA | SOUTHERN HEALTH |
11359 | Other | VA | CIGNA |
006703666 | Medicaid | VA | |
21814 | Other | VA | CARENT |
1200322 | Other | VA | UNITED HEALTH CARE |
317420 | Other | VA | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 0101035064 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joel C Everett, MD Po Box 549, Midlothian, VA 23113-0549 Ph: (804) 794-2821 | Dr Joel C Everett, MD 13821 Village Mill Dr, Midlothian, VA 23114-4365 Ph: (804) 794-2821 |
News Archive
A study performed on the NASA Space Shuttle Discovery showed that exposure of mouse embryonic stem cells (mESCs) to microgravity inhibited their ability to differentiate and generate most cell lineages, needed for the development of bone, muscle, the immune system, and other organs and tissues.
Among infectious diseases that have caused pandemics and epidemics, smallpox stands out as a success story. Smallpox vaccination led to the disease's eradication in the twentieth century.
Researchers at the University of California, San Diego School of Medicine have identified the gene mutation responsible for a particularly severe form of pontocerebellar hypoplasia, a currently incurable neurodegenerative disease affecting children.
Millennium: The Takeda Oncology Company today reported new correlative science data from the pivotal PINNACLE trial of VELCADE (bortezomib) in patients with relapsed/refractory mantle cell lymphoma. The data, derived from an analysis of archived tumor samples, tested pre-specified biomarkers for their association with time to progression and response to treatment with VELCADE in patients with relapsed MCL.
A new method for creating nanofibers made of proteins, developed by researchers at Polytechnic Institute of New York University (NYU-Poly), promises to greatly improve drug delivery methods for the treatment of cancers, heart disorders and Alzheimer's disease, as well as aid in the regeneration of human tissue, bone and cartilage.
› Verified 6 days ago
Arpita Gupta Depalma, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11601 Robious Rd, Suite 100, Midlothian, VA 23113 Phone: 804-379-9494 | |
Dr. Linda A Burk, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 16213 Saville Chase Ln, Midlothian, VA 23112 Phone: 804-432-8817 | |
Dr. Gordon Neil Kellett Ii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13821 Village Mill Dr, Midlothian, VA 23114 Phone: 804-794-2821 Fax: 804-794-4072 | |
Dr. Mark A Flanzenbaum, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5021 Craig Rath Blvd Bldg 4, Midlothian, VA 23112 Phone: 804-592-5437 Fax: 804-474-9071 | |
Dr. Elizabeth Marie Cullen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1407 Huguenot Rd, Midlothian, VA 23113 Phone: 804-794-2299 Fax: 804-794-5774 | |
Isca Rochelle Wilms, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13700 St Francis Blvd, Suite 501, Midlothian, VA 23114 Phone: 804-378-4420 Fax: 804-378-4440 |